Celastrol enhanced CD8+T cell immunity in melanoma by targeting SHP2 and upregulating MHC-I
{{output}}
Background: Celastrol (CEL) has demonstrated promising anti-cancer properties, yet its specific mechanisms against melanoma remain insufficient. This study investigated the CEL's anti-tumor effects and determined its potential m... ...
